cro.directory
← Compare landing

Axxam vs Pharma Inventor

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/axxam/pharmainventor

CategoryAxxamPharma Inventor
Listed sitecrocro
SummaryContract research organization specializing in integrated drug discovery services, from target validation to hit and lead identification across therapeutic areas.Vancouver-based preclinical drug discovery CRO offering medicinal chemistry, custom synthesis, LC-MS/MS bioanalysis, high-throughput screening and ADC development for pharma and biotech teams. Lists 6,000+ sq ft of research facilities and in-house 400 MHz NMR.
Services
  • Target Identification & Validation
  • Discovery Research
  • High-Throughput Screening
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Preclinical In Vitro Studies
  • Medicinal Chemistry
  • Analytical Method Development & Validation
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • In Vitro ADME / DMPK
  • High-Throughput Screening
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Target Identification & Validation
  • Computational & In-Silico Drug Discovery
  • Discovery Research
ModalitiesData not yet provided.
  • Small Molecule
  • Peptide
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters and laboratories, Bresso, Milan, Italy
  • Laboratories, Torre Annunziata, Naples, Italy
  • Business development office, Cambridge, Massachusetts, USA
  • Business development office, Copenhagen, Denmark
  • Business development office, Basel, Switzerland
  • Headquarters, Vancouver, British Columbia, Canada
Certifications
  • ISO · Identifier: ISO 9001:2015
  • ISO · Identifier: ISO 45001:2018
  • ISO · Identifier: ISO/IEC 27001:2024
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.